Troy Bio Overview

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Troy Bio General Information

Description

Developer of an enzyme replacement therapy delivery platform designed for the treatment of orphan diseases. The company's platform combines transferrin receptor1 antibodies with therapeutic enzymes, increasing their bioavailability in the central nervous system and muscles, enabling the healthcare industry to treat regimen for rare hereditary diseases such as Hunter syndrome and Pompe disease.

Contact Information

Website
www.troy-bio.ru
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1, room 2-037
  • Federal Territory Sirius, Triumfalny proez
  • Krasnodar Krai, 354340
  • Russia
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 1, room 2-037
  • Federal Territory Sirius, Triumfalny proez
  • Krasnodar Krai, 354340
  • Russia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Troy Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jul-2024 Completed Startup
To view Troy Bio’s complete valuation and funding history, request access »

Troy Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Unicorn Capital Partners Venture Capital Minority
To view Troy Bio’s complete investors history, request access »

Troy Bio FAQs

  • Where is Troy Bio headquartered?

    Troy Bio is headquartered in Krasnodar Krai, Russia.

  • What industry is Troy Bio in?

    Troy Bio’s primary industry is Therapeutic Devices.

  • Is Troy Bio a private or public company?

    Troy Bio is a Private company.

  • What is Troy Bio’s current revenue?

    The current revenue for Troy Bio is .

  • Who are Troy Bio’s investors?

    Unicorn Capital Partners has invested in Troy Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process